| 1. | | No longer recruiting | AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 2. | | Suspended | BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 3. | | Recruiting | CA-125 in Screening Patients at High Risk for Ovarian Cancer
Condition: ovarian epithelial cancer |
| 4. | | No longer recruiting | Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
Condition: ovarian epithelial cancer |
| 5. | | Recruiting | Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
Condition: actinic keratosis |
| 6. | | Completed | Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer
Conditions: recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; Quality of Life; recurrent rectal cancer; ... |
| 7. | | Completed | Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
Conditions: stage III pancreatic cancer; Quality of Life; adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; ... |
| 8. | | Completed | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 9. | | Completed | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer
Conditions: Lung Cancer; Pancreatic Cancer; Colorectal Cancer; Colon Cancer; Breast Cancer |
| 10. | | Completed | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer; limited stage small cell lung cancer |
| 11. | | Completed | Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; stage III colon cancer; Stage IV rectal cancer; stage II colon cancer; stage II rectal cancer; stage IV colon cancer; ... |
| 12. | | No longer recruiting | Fenretinide in Treating Patients With Leukoplakia of the Mouth
Condition: prevention of oral cancer |
| 13. | | Completed | Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor
Conditions: stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 14. | | Completed | Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants
Conditions: Leukemia; Lymphoma |
| 15. | | No longer recruiting | Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
Conditions: stage I melanoma; stage II melanoma; stage III melanoma |
| 16. | | No longer recruiting | ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
Conditions: stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas |
| 17. | | Completed | ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer
Conditions: recurrent colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ... |
| 18. | | No longer recruiting | L-377,202 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: recurrent prostate cancer |
| 19. | | No longer recruiting | Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma
Conditions: AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ... |
| 20. | | No longer recruiting | Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma; stage III melanoma; Recurrent Melanoma |
| 21. | | No longer recruiting | Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 22. | | Completed | Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy
Conditions: stage I prostate cancer; stage II prostate cancer; stage III prostate cancer |
| 23. | | No longer recruiting | Phase I/II Study of Cetuximab, Gemcitabine, and Carboplatin in Patients With Chemotherapy-Naive Stage IV Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 24. | | No longer recruiting | Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
Condition: Purpura, Thrombocytopenic, Idiopathic |
| 25. | | Recruiting | Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
Condition: Herpes Simplex |
| 26. | | Completed | Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth
Condition: Herpes Simplex |
| 27. | | No longer recruiting | Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
Conditions: recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the hypopharynx; ... |
| 28. | | No longer recruiting | Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
Conditions: Oral Cancer; Throat Cancer |
| 29. | | No longer recruiting | Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
| 30. | | Recruiting | Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma |
| 31. | | Recruiting | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ... |
| 32. | | No longer recruiting | Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 33. | | Completed | Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus |
| 34. | | Completed | Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture
Condition: Systemic Lupus Erythematosus |
| 35. | | Recruiting | T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
Conditions: recurrent skin cancer; basal cell carcinoma of the skin; squamous cell carcinoma of the skin; actinic keratosis |
| 36. | | No longer recruiting | Vaccine Therapy in Treating Patients With Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 37. | | No longer recruiting | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
Conditions: recurrent ovarian epithelial cancer; stage IV non-small cell lung cancer; unspecified adult solid tumor, protocol specific; ... |
